: iStockAnalyst.com Symbols Feed

11 Stocks That Are Going Through The Roof

Thu, 18 Dec 2008 16:25:00 GMT

Sent early to TIMalert subscribers , lots of people banking, don’t you wish you were one of them? 9I do, I didn’t trade at all, but thanks to the success of my instructional DVDs , my... Visit TimothySykes.com to read full article with comments [More...]

10 Hot Stocks, One Of Which I Coulda Woulda Shoulda Bought & Banked aka Hindsight Is Easy

Wed, 17 Dec 2008 17:01:00 GMT

Sent to TIMalert subscribers early this morning, guess I shouldn’t have been such a little baby on ANSV, sometimes you gotta buy a stock up 700% because the percent gain isn’t as... Visit TimothySykes.com to read full article with comments [More...]

Analyst Comments: DexCom, Dr. Pepper, Aetna, Array BioPharma, ConEd, Williams Companies, Dell, Tech Data, Aventine, Allscripts, Anesiva

Wed, 13 Aug 2008 12:23:00 GMT

DexCom, Inc. (DXCM) reported a second-quarter net loss of $0.48 per share compared with a net loss of $0.40 per share in the comparable period last year. We are pleased with top line product revenue growth and are encouraged by the recently announced cont[More...]

Few Thoughts and a Look at the Earnings in the Coming Week

Mon, 28 Jul 2008 05:15:00 GMT

WITH RESPECT TO THE US’ GDP GROWTH, THE NATIONAL BUREAU OF ECONOMIC RESEARCH SEES A SIGNIFICANT DECLINE IN ECONOMIC ACTITIVY SPREAD ACROSS THE ECONOMY, WHICH WILL LAST MORE THAN A FEW MONTHS - WSJ - According to Robert Hall, economist at Stanford University, US economic data that has been reported provide (...)[More...]

Analyst Commentsts: Coke, Unilever, Anesiva, Immucor, Morton's

Tue, 01 Jul 2008 17:50:18 GMT

The Coca-Cola Company (KO) has strong soft drink brands, leading market shares, and generates solid cash flow. The company's new Chief Executive Officer, Muhtar Kent, will continue with predecessor Isdell's revitalization plan to deal with the challenges of sluggish volume trends. While focusing on the long-term objective of high single-digit earnings per share growth, the management is improving the Coca-Cola...[More...]

Analyst Comments: Anesiva, Concur Technologies, Standard Motor, TIM, Greenfield

Fri, 09 May 2008 18:56:03 GMT

Anesiva, Inc. (ANSV) plans to launch Zingo, a product we see having at least $200 million potential, in June 2008. We are big fans of Zingo and expect the stock to outperform once the market comes to grips with the product potential. In the meantime, development plans with Adlea, a potential billion-dollar blockbuster for post-surgical pain, is progressing nicely in phase III trials. As such, we think...[More...]

NASDAQ Technical Picture - Narrow Range Ahead of FED

Wed, 30 Apr 2008 06:06:27 GMT

Another choppy, mixed day ahead of the FED. Experts are calling for 0.25 BP cut and a statement discussing potential pause. I don't expect markets to rally on that news, but we'll soon see.[More...]

Analyst Comments: Anesiva, iPass, Auxilum, Skyworks

Wed, 02 Apr 2008 14:21:44 GMT

In the past several months, Anesiva, Inc. (ANSV) has gained approval for Zingo, unveiled its marketing strategy, prepared for the commercial launch in the second quarter of 2008, formed three alliances for Zingo for the U.S., Europe and Canadian markets,[More...]

Rhyme Nor Reason

Thu, 21 Feb 2008 13:23:12 GMT

Good morning. We start the day with a positive bias. Rallies in overseas markets, more speculation concerning worldwide bank rescues, a little M&A activity, some buying interest in technology (CSCO, RIMM, HPQ), and falling jobless claims are this morning'[More...]

Analyst Comments: National Semi, Iomega, Anesiva, Borg Warner, Northrop Grumman, FormFactor, Kenexa, NuStar, Washington Mutual,

Wed, 13 Feb 2008 03:58:46 GMT

National Semiconductor (NSM) is an OEM of analog and mixed signal integrated circuits. November quarter revenue was in-line with consensus estimates, although the EPS exceeded. Revised guidance for the second quarter is for...[More...]

Anesiva, Inc. And Arcion Therapeutics Announce Merger Agreement ; - Creates New Company Focused on Targeted Pain Therapeutics That Address Large Markets With Unmet Needs -; - Conference Call Scheduled for Wednesday, August 5, 2009 at 8:30 AM EDT -

Wed, 05 Aug 2009 11:46:00 GMT

SOUTH SAN FRANCISCO, Calif., and BALTIMORE, Aug. 5 /PRNewswire- FirstCall/ -- Anesiva, Inc. (Nasdaq: ANSV) and Arcion Therapeutics, Inc., a privately held company, announced today the signing of a definitive merger agreement.
Upon closing of the merger, Arcion and Anesiva shareholders will own approximately 64% and 36%, respectively, of the outstanding shares of the combined company.
Closing of the merger is contingent upon, among other conditions, a vote of approval by Anesiva's current shareholders.

: iStockAnalyst.com Symbols Feed

11 Stocks That Are Going Through The Roof

10 Hot Stocks, One Of Which I Coulda Woulda Shoulda Bought & Banked aka Hindsight Is Easy

Analyst Comments: DexCom, Dr. Pepper, Aetna, Array BioPharma, ConEd, Williams Companies, Dell, Tech Data, Aventine, Allscripts, Anesiva

Few Thoughts and a Look at the Earnings in the Coming Week

Analyst Commentsts: Coke, Unilever, Anesiva, Immucor, Morton's

Analyst Comments: Anesiva, Concur Technologies, Standard Motor, TIM, Greenfield

NASDAQ Technical Picture - Narrow Range Ahead of FED

Analyst Comments: Anesiva, iPass, Auxilum, Skyworks

Rhyme Nor Reason

Analyst Comments: National Semi, Iomega, Anesiva, Borg Warner, Northrop Grumman, FormFactor, Kenexa, NuStar, Washington Mutual,

Anesiva, Inc. And Arcion Therapeutics Announce Merger Agreement ; - Creates New Company Focused on Targeted Pain Therapeutics That Address Large Markets With Unmet Needs -; - Conference Call Scheduled for Wednesday, August 5, 2009 at 8:30 AM EDT -

Anesiva, Inc. and Arcion Therapeutics Announce Merger Agreement

Anesiva Announces Going Concern Opinion and Nasdaq Notice - Apr 1 2009 11:10PM

Anesiva Announces Going Concern Opinion and Nasdaq Notice - Apr 1 2009 8:52PM

Anesiva Announces Planned Rights Offering

Biotechnology Value Fund Urges Stockholders to Remove and Replace Current Board of Avigen, Inc. In an Effort to Protect and Maximize Stockholder Value

Anesiva Announces FDA Approval of Supplemental New Drug Application to Expand Zingo(TM) Indication

Anesiva Announces Changes to Its Board of Directors and Receives Notification From Nasdaq

BenchmarkJournal.Com (Complimentary) Analyst Review for DTV, ANSV, STEC and FFIV

Anesiva Phase 3 Trial of Adlea Meets Primary Endpoint to Significantly Reduce Pain After Total Knee Replacement Surgery

Form 3 Tran John H. For: Feb 18 (10K)

Form 4 ANESIVA, INC. For: Feb 12 Filed by: HAMILTON JOHN F (10K)

Form 3 ANESIVA, INC. For: Feb 12 Filed by: HAMILTON JOHN F (10K)

Form 4 Viret Jean-Frederic For: Dec 03 (10K)

Form 4 HOUGHTON WILLIAM C For: Dec 03 (10K)

Form 4 Kranda Michael L For: Dec 03 (10K)

Form 4 ANESIVA, INC. For: Oct 14 Filed by: HOUGHTON WILLIAM C (10K)

Form 4 ANESIVA, INC. For: Oct 14 Filed by: Donahue Nancy E (10K)

Form 4 ANESIVA, INC. For: Oct 14 Filed by: Viret Jean-Frederic (10K)

Form 3 ANESIVA, INC. For: Sep 01 Filed by: HOUGHTON WILLIAM C (10K)